BBLG
Bone Biologics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.15M
P/E Ratio
—
EPS
$-2.65
Beta
0.37
52W High
$6.75
52W Low
$1.05
50-Day MA
$1.29
200-Day MA
$2.09
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Bone Biologics Corp
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | -824,964 |
| Operating Margin | 0.00% |
| Return on Equity | -70.20% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.00 |
| Price-to-Book | 0.41 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.80M |
| Float | $1.79M |
| % Insiders | 0.04% |
| % Institutions | 2.85% |
Analyst Ratings
Consensus ($22.20 target)
Data last updated: 4/7/2026